AI assistant
Xylem Inc. — Director's Dealing 2026
Mar 3, 2026
30109_dirs_2026-03-03_d2265453-026a-415b-baf1-1a4e2d9db7bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Xylem Inc. (XYL)
CIK: 0001524472
Period of Report: 2026-03-01
Reporting Person: Cho Albert (EVP, Strategy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-03-01 | Common Stock | A | 1311 | $128.98 | Acquired | 15418 | Direct |
| 2026-03-01 | Common Stock | A | 1082 | $128.98 | Acquired | 16500 | Direct |
| 2026-03-01 | Common Stock | A | 735 | $128.98 | Acquired | 17235 | Direct |
| 2026-03-01 | Common Stock | A | 587 | $128.98 | Acquired | 17822 | Direct |
| 2026-03-02 | Common Stock | A | 1042 | — | Acquired | 18864 | Direct |
| 2026-03-02 | Common Stock | F | 1610 | $128.98 | Disposed | 17254 | Direct |
| 2026-03-02 | Common Stock | F | 295 | $128.98 | Disposed | 16959 | Direct |
| 2026-03-02 | Common Stock | F | 371 | $128.98 | Disposed | 16588 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | Non-Qualified Stock Options (Right to Buy) | $128.98 | A | 3713 | Acquired | 2036-03-02 | Common Stock (3713) | Direct |
Footnotes
F1: Reflects the acquisition of 1,311 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.
F2: Includes additional shares due to dividend reinvestment.
F3: Reflects the acquisition of 1,082 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.
F4: Reflects the acquisition of 735 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.
F5: Reflects the acquisition of 587 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance.
F6: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
F7: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).
F8: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).
F9: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (207) and March 1, 2024 (164) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
F10: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.